Search Results - Moser, Matthias
- Showing 1 - 4 results of 4
-
1
Monitoring Cell Death in Regorafenib-Treated Experimental Colon Carcinomas Using Annexin-Based Optical Fluorescence Imaging Validated by Perfusion MRI by Kazmierczak, Philipp M., Burian, Egon, Eschbach, Ralf, Hirner-Eppeneder, Heidrun, Moser, Matthias, Havla, Lukas, Eisenblätter, Michel, Reiser, Maximilian F., Nikolaou, Konstantin, Cyran, Clemens C.
Published 2015Text -
2
Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immuno... by Eschbach, Ralf Stefan, Clevert, Dirk-Andre, Hirner-Eppeneder, Heidrun, Ingrisch, Michael, Moser, Matthias, Schuster, Jessica, Tadros, Dina, Schneider, Moritz, Kazmierczak, Philipp Maximilian, Reiser, Maximilian, Cyran, Clemens C.
Published 2017Text -
3
Regorafenib Effects on Human Colon Carcinoma Xenografts Monitored by Dynamic Contrast-Enhanced Computed Tomography with Immunohistochemical Validation by Cyran, Clemens C., Kazmierczak, Philipp M., Hirner, Heidrun, Moser, Matthias, Ingrisch, Michael, Havla, Lukas, Michels, Alexandra, Eschbach, Ralf, Schwarz, Bettina, Reiser, Maximilian F., Bruns, Christiane J., Nikolaou, Konstantin
Published 2013Text -
4
Correlation of Perfusion MRI and (18)F-FDG PET Imaging Biomarkers for Monitoring Regorafenib Therapy in Experimental Colon Carcinomas with Immunohistochemical Validation by Eschbach, Ralf S., Fendler, Wolfgang P., Kazmierczak, Philipp M., Hacker, Marcus, Rominger, Axel, Carlsen, Janette, Hirner-Eppeneder, Heidrun, Schuster, Jessica, Moser, Matthias, Havla, Lukas, Schneider, Moritz J., Ingrisch, Michael, Spaeth, Lukas, Reiser, Maximilian F., Nikolaou, Konstantin, Cyran, Clemens C.
Published 2015Text